November 1, 2009
By:Charles Bankhead
Patients in active surveillance for prostate cancer were almost 20 times more likely to die of causes other than prostate cancer.
 |
November 1, 2009
By:Urology Times staff
Cardiometabolic disorders and urologic disease represent a "perfect storm" of ailments, according to Kevin T. McVary, MD, who discusses the urologist's role in management.
|
November 1, 2009
By:Mac Overmyer
Postoperative pharmacologic therapy enhances the chances of erectile function recovery in virtually all categories of men who undergo bilateral nerve-sparing prostatectomy.
|
November 1, 2009
By:Charles Bankhead
Compared with the general population, prostate cancer patients treated with radiation therapy were almost twice as likely to develop rectal cancer.
|
November 1, 2009
By:Cheryl Guttman
Benign PSA, measured in serum with a proprietary automated assay, improves prostate cancer detection when it is incorporated into an artificial neural network.
|
November 1, 2009
By:Wayne Kuznar
A diagnosis of diabetes or cardiometabolic disorders was not associated with an increased risk of incident prostate cancer, but rather a decreased incidence of the disease.
|
November 1, 2009
By:Cheryl Guttman
Robotic prostatectomy in morbidly obese men is feasible, reasonably safe, and appears to provide oncologic control comparable to that achieved in a normal weight population.
|
November 1, 2009
By:David B. Samadi, MD, Hugh J. Lavery, MD
Since the original description of the robot-assisted laparoscopic prostatectomy technique in 2002, several technical modifications have been reported.
|
| 
Practice Tools
Brings you the latest news and information twice each month.